Bayer Bets On Oncology Pipeline, Vows To Increase 2017 R&D Budget

 
• By Lucie Ellis-Taitt
Bayer Board
Bayer Execs In Leverkusen (L-R): Johannes Dietsch, Werner Baumann, Hartmut Klusik and Michael Preuss • Source: Scrip/ Lucie Ellis

More from Anticancer

More from Therapeutic Category